[HTML][HTML] Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children
…, SJ Teach, JA Pongracic, JF Chmiel… - … England Journal of …, 2011 - Mass Medical Soc
Background Research has underscored the effects of exposure and sensitization to allergens
on the severity of asthma in inner-city children. It has also revealed the limitations of …
on the severity of asthma in inner-city children. It has also revealed the limitations of …
[HTML][HTML] Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
AM Cantin, D Hartl, MW Konstan, JF Chmiel - Journal of Cystic Fibrosis, 2015 - Elsevier
Lung disease is the major cause of morbidity and mortality in patients with cystic fibrosis (CF).
Although CF lung disease is primarily an infectious disorder, the associated inflammation …
Although CF lung disease is primarily an infectious disorder, the associated inflammation …
Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized …
…, CAD Burnham, M Cabana, M Castro, JF Chmiel… - Jama, 2015 - jamanetwork.com
Importance Many preschool children develop recurrent, severe episodes of lower respiratory
tract illness (LRTI). Although viral infections are often present, bacteria may also contribute …
tract illness (LRTI). Although viral infections are often present, bacteria may also contribute …
[HTML][HTML] State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?
JF Chmiel, PB Davis - Respiratory research, 2003 - Springer
Cystic Fibrosis (CF) lung disease, which is characterized by airway obstruction, chronic
bacterial infection, and an excessive inflammatory response, is responsible for most of the …
bacterial infection, and an excessive inflammatory response, is responsible for most of the …
The role of inflammation in the pathophysiology of CF lung disease
JF Chmiel, M Berger, MW Konstan - Clinical reviews in allergy & …, 2002 - Springer
Cystic fibrosis (CF) lung disease is characterized by a self-perpetuating cycle of airway
obstruction, chronic bacterial infection, and vigorous inflammation that results in structural …
obstruction, chronic bacterial infection, and vigorous inflammation that results in structural …
Individualized therapy for persistent asthma in young children
…, SN Baxi, M Benson, K Blake, JF Chmiel… - Journal of Allergy and …, 2016 - Elsevier
Background Phenotypic presentations in young children with asthma are varied and might
contribute to differential responses to asthma controller medications. Methods The …
contribute to differential responses to asthma controller medications. Methods The …
Inflammation and its genesis in cystic fibrosis
DP Nichols, JF Chmiel - Pediatric pulmonology, 2015 - Wiley Online Library
The host inflammatory response in cystic fibrosis (CF) lung disease has long been recognized
as a central pathological feature and an important therapeutic target. Indeed, many …
as a central pathological feature and an important therapeutic target. Indeed, many …
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus, Gram-Negative Bacteria, and Multiple …
JF Chmiel, TR Aksamit, SH Chotirmall… - Annals of the …, 2014 - atsjournals.org
… Correspondence and requests for reprints should be addressed to James F. Chmiel, MD,
MPH, Division of Pediatric Pulmonology and Allergy/Immunology, Room 3001, Rainbow …
MPH, Division of Pediatric Pulmonology and Allergy/Immunology, Room 3001, Rainbow …
Inflammation in cystic fibrosis: An update
EA Roesch, DP Nichols, JF Chmiel - Pediatric pulmonology, 2018 - Wiley Online Library
Inflammation plays a critical role in cystic fibrosis (CF) lung pathology and disease progression
making it an active area of research and important therapeutic target. In this review, we …
making it an active area of research and important therapeutic target. In this review, we …
Airway microbiota across age and disease spectrum in cystic fibrosis
…, CE Robertson, RC Ahrens, JF Chmiel… - European …, 2017 - Eur Respiratory Soc
Our objectives were to characterise the microbiota in cystic fibrosis (CF) bronchoalveolar
lavage fluid (BALF), and determine its relationship to inflammation and disease status. BALF …
lavage fluid (BALF), and determine its relationship to inflammation and disease status. BALF …